Literature DB >> 35727395

Neutrophil-lymphocyte Ratio and C-Reactive Protein Levels are not Associated with Strength, Muscle Mass, and Functional Capacity in Kidney Transplant Patients.

Heitor O Santos1, Larissa S Limirio1, Aline S Dos Reis1, Rafaela Nehme1, João Pedro Floriano1, Gederson K Gomes1, Gustavo D Pimentel2, Erick P de Oliveira3.   

Abstract

Chronic inflammation has been associated with components of sarcopenia; however, these associations are unknown in kidney transplant patients (KTPs). The aim of this study was to associate neutrophil-lymphocyte ratio (NLR) and C-reactive protein (CRP) with strength, muscle mass, and functional capacity in KTPs. A cross-sectional study evaluating 108 KTPs was performed. Strength was evaluated by handgrip strength and five-times-sit-to-stand test (5STS), and appendicular skeletal muscle mass (ASM) was estimated by bioelectrical impedance analysis. The ASM index (ASMI) was calculated using the ASM (kg)/height (m2). Functional capacity was assessed by the 4-m gait speed test and short physical performance battery (SPPB). The electrochemiluminescence method was used for analyzing CRP levels, and the cytometric method XN-3000 Sysmex was used for obtaining leukogram values to calculate the NLR. Linear regression analysis was used to assess the association between systemic inflammation and sarcopenia components, adjusting for confounders. NLR and CRP levels were not associated with handgrip strength (β =  - 0.231, p = 0.389; β =  - 0.291, p = 0.577), 5STS (β =  - 0.114, p = 0.288; β =  - 0.202, p = 0.334), ASM (β =  - 0.027, p = 0.813; β = 0.062, p = 0.788), ASMI (β =  - 0.036, p = 0.242; β = 0.040, p = 0.505), 4-m gait speed (β = 0.013, p = 0.082; β = 0.004, p = 0.769), and SPPB (β = 0.076, p = 0.170; β = 0.152, p = 0.157), respectively. In conclusion, NLR and CRP levels were not associated with muscle mass, strength, and functional capacity in KTPs.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  C-reactive protein; Inflammation; Kidney transplant patients; Neutrophil–lymphocyte ratio; Sarcopenia

Year:  2022        PMID: 35727395     DOI: 10.1007/s10753-022-01705-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

1.  (Dis) Agreement between the first and the recent European consensus on definition and diagnosis for sarcopenia in kidney transplant patients.

Authors:  Larissa S Limirio; Heitor O Santos; Aline S Dos Reis; Erick P de Oliveira
Journal:  Eur J Clin Nutr       Date:  2019-11-25       Impact factor: 4.016

Review 2.  Oxidative stress in kidney transplantation: causes, consequences, and potential treatment.

Authors:  Mohsen Nafar; Zahra Sahraei; Jamshid Salamzadeh; Shiva Samavat; Nosartolah D Vaziri
Journal:  Iran J Kidney Dis       Date:  2011-11       Impact factor: 0.892

3.  Factors Related to Osteosarcopenia in Kidney Transplant Recipients.

Authors:  M Yanishi; H Kinoshita; H Tsukaguchi; Y Kimura; Y Koito; M Sugi; T Matsuda
Journal:  Transplant Proc       Date:  2018-04-18       Impact factor: 1.066

Review 4.  Physical Activity in Kidney Transplant Recipients: A Review.

Authors:  Ashley Takahashi; Susie L Hu; Andrew Bostom
Journal:  Am J Kidney Dis       Date:  2018-02-23       Impact factor: 8.860

5.  Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: The Yakumo study.

Authors:  Tetsuro Hida; Shiro Imagama; Kei Ando; Kazuyoshi Kobayashi; Akio Muramoto; Kenyu Ito; Yoshimoto Ishikawa; Mikito Tsushima; Yoshihiro Nishida; Naoki Ishiguro; Yukiharu Hasegawa
Journal:  Mod Rheumatol       Date:  2017-07-25       Impact factor: 3.023

6.  Evaluation of physical activity in sarcopenic conditions of kidney transplantation recipients.

Authors:  Masaaki Yanishi; Hiroyasu Tsukaguchi; Yutaka Kimura; Yuya Koito; Kenji Yoshida; Maiko Seo; Eri Jino; Motohiko Sugi; Hidefumi Kinoshita; Tadashi Matsuda
Journal:  Int Urol Nephrol       Date:  2017-07-19       Impact factor: 2.370

7.  Intake of polyunsaturated fatty acids and ω-3 are protective factors for sarcopenia in kidney transplant patients.

Authors:  Aline S Dos Reis; Larissa S Limirio; Heitor O Santos; Erick P de Oliveira
Journal:  Nutrition       Date:  2020-07-03       Impact factor: 4.008

8.  Inflammatory markers and incident mobility limitation in the elderly.

Authors:  Brenda W J H Penninx; Stephen B Kritchevsky; Anne B Newman; Barbara J Nicklas; Eleanor M Simonsick; Susan Rubin; Michael Nevitt; Marjolein Visser; Tamara Harris; Marco Pahor
Journal:  J Am Geriatr Soc       Date:  2004-07       Impact factor: 5.562

Review 9.  Sarcopenia in older adults.

Authors:  Jeremy D Walston
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

10.  Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis.

Authors:  Camilla S L Tuttle; Lachlan A N Thang; Andrea B Maier
Journal:  Ageing Res Rev       Date:  2020-09-26       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.